Crossmark

Correction to: Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome

Crossref DOI link: https://doi.org/10.1038/s41416-023-02211-3

Published Online: 2023-03-20

Published Print: 2023-05-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhou, Quan

Ou, Yuxi

Dai, Xiyu

Chen, Xinan

Wu, Siqi

Chen, Wensun

Hu, Mengbo https://orcid.org/0000-0001-7625-2026
Yang, Chen https://orcid.org/0000-0001-6011-4067
Zhang, Limin https://orcid.org/0000-0002-8470-1247
Jiang, Haowen https://orcid.org/0000-0002-5349-1363
License Information

Text and Data Mining valid from 2023-03-20

Version of Record valid from 2023-03-20
More Information

Article History

First Online: 20 March 2023

Free to read: This content has been made available to all.